Atlas Trials

Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors

Clinical trial NCT06279494 · UNKNOWN

Trial details

NCT number
NCT06279494
Sponsor
Peking University People's Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute LeukemiaMyelodysplastic SyndromesSevere Aplastic Anemia
Start date
2024-03-01
Primary completion
2024-06-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.